Recent health reforms in Pakistan increase market prospects: Fitch

Fitch Solutions recently released a report on how health reforms in Pakistan will improve market prospects.

The report noted that the new national health insurance scheme would be positive for the health sector in Pakistan, with a new impetus for a favorable reform of the opportunities offered to drug manufacturers.

According to Fitch, the PTI government has outlined a series of reforms to promote public health in the country in its 2018 election manifesto. Prime Minister Imran Khan aims to ensure universal coverage of medical care and medical care. put more emphasis on primary care when modernizing secondary and tertiary care facilities. .

The Prime Minister re-launched the first phase of the health insurance scheme in February 2019, which was introduced by the previous government of the Muslim League of Pakistan-Nawaz as Prime Minister of the National Health Program (PMNHP) in 2015, under the new title of Sehat Insaf Card.

According to the program, vulnerable families can benefit from free treatment up to 720,000 PKR (USD 5,151) per year in 150 public and private hospitals. A wide range of inpatient medical and surgical services is included in the program, which includes surgeries, tricks, chemotherapy, radiation therapy, dialysis, maternity, and other medical and surgical services.

In addition, the Sehat Insaf program will benefit about 15 million people currently living below the poverty line. It is expected that by the end of the program, 14 million families will be enrolled in the plan.

In addition, reforms to ensure the availability of diagnostic services and the preventive and curative treatment of communicable diseases such as hepatitis, tuberculosis and HIV were also highlighted in the ITP manifesto.

It is likely that Pakistan's pharmaceutical and health care reforms will be implemented over a longer period, which will support the sector in its growth trajectory. However, opportunities for multinational drug manufacturers will continue to be affected by the underlying problems within the health systems described in the report.

Fitch suggests that the prospects of multinational pharmaceutical companies in Pakistan remain bleak. Despite Pakistan's growing political will to develop the health sector, given the government's poor track record in implementing the planned reforms in the health sector, it is possible that the implementation of these improvements could be delayed.

He also noted that many weaknesses will affect the development of the sector, including poor governance, lack of access and unequal resources, weak health information management systems, corruption in the health system, lack of supervision. in health policies and planning and the lack of qualified personnel.

Fitch will continue to monitor market developments that may affect the health and pharmacy sectors.

However, the report also suggests that the growing burden of chronic disease, the aging of the population and health care reforms will continue to contribute to the growth of the pharmaceutical market.

Post a Comment